Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,576 | -4,112 | -3,140 | -1,715 | -12,543 |
| Depreciation Amortization | 4 | 3 | 2 | 1 | 10 |
| Accounts receivable | N/A | N/A | N/A | N/A | 1,481 |
| Accounts payable and accrued liabilities | 334 | -437 | 17 | 111 | -2,256 |
| Other Working Capital | 772 | 103 | 549 | 283 | -968 |
| Other Operating Activity | -60 | 660 | 146 | -34 | 1,430 |
| Operating Cash Flow | $-4,525 | $-3,783 | $-2,426 | $-1,354 | $-12,846 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,527 | 1,527 | 89 | 0 | 6,921 |
| Other Financing Activity | -467 | -360 | -290 | -173 | -281 |
| Financing Cash Flow | $1,060 | $1,167 | $-201 | $-173 | $6,640 |
| Beginning Cash Position | 5,900 | 5,900 | 5,900 | 5,900 | 12,106 |
| End Cash Position | 2,435 | 3,284 | 3,273 | 4,373 | 5,900 |
| Net Cash Flow | $-3,465 | $-2,616 | $-2,627 | $-1,527 | $-6,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,525 | -3,783 | -2,426 | -1,354 | -12,846 |
| Free Cash Flow | -4,525 | -3,783 | -2,426 | -1,354 | -12,846 |